Literature DB >> 1728487

Quantitative angiographic morphology of the coronary artery lesions at risk of thrombotic occlusion.

Y Taeymans1, P Théroux, J Lespérance, D Waters.   

Abstract

BACKGROUND: Coronary angiography in acute myocardial infarction has revealed complicated atherosclerotic plaque and a high rate of thrombotic occlusion. However, the characteristics of lesions at high risk of subsequent occlusion are not well known. METHODS AND
RESULTS: In the present study, the qualitative and quantitative angiographic features of 38 coronary artery lesions that occluded within 3 years to cause an acute myocardial infarction were compared with 64 control segments from the same patients that did not occlude. Compared with control lesions, the lesions that occluded were more likely to have a division branch originating within the stenosis (76% versus 52%, p less than 0.05). The percent lumen diameter reduction was more severe (47.5 +/- 17.8% versus 41 +/- 12.5%, p less than 0.05) and the inflow (21 +/- 10 degrees versus 16 +/- 7 degrees, p less than 0.05) and outflow (20 +/- 10 degrees versus 16 +/- 8 degrees, p less than 0.05) angles of the stenosis were steeper. Time to myocardial infarction after the angiogram interacted with the importance of these features (p less than 0.02). Thus, paired analysis of the lesions that occluded within 3 months and of the most severe control lesion from each patient showed percent lumen diameter reduction of 62.1 +/- 11.5% and 46.4 +/- 11.4%, respectively (p less than 0.001). The length of the stenosis, its asymmetry, and the irregularity of the contours did not help differentiate occlusive from control segments.
CONCLUSIONS: Coronary artery lesions at high risk of thrombotic occlusion share common characteristics that favor higher shear stress and flow separation.

Entities:  

Mesh:

Year:  1992        PMID: 1728487     DOI: 10.1161/01.cir.85.1.78

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  9 in total

1.  Measuring progression and regression of coronary atherosclerosis in clinical trials: problems and progress.

Authors:  J Lespérance; D Waters
Journal:  Int J Card Imaging       Date:  1992

2.  Disease progression and adverse events in patients listed for elective percutaneous coronary intervention.

Authors:  S Talwar; M Karpha; R Thomas; C Vurwerk; I C Cox; C J Burrell; J G Motwani; T J Gilbert; G A Haywood
Journal:  Postgrad Med J       Date:  2005-07       Impact factor: 2.401

3.  What percent luminal stenosis should be used to define angiographic coronary artery disease for noninvasive test evaluation?

Authors:  Michael Lipinski; Dat Do; Anthony Morise; Victor Froelicher
Journal:  Ann Noninvasive Electrocardiol       Date:  2002-04       Impact factor: 1.468

4.  Clinical and angiographic variables affecting the progression of coronary artery disease as determined by quantitative angiography.

Authors:  A Joseph; J D Talley; A Shih; T Crum; R Vogel; J Kupersmith
Journal:  Int J Card Imaging       Date:  1994-09

Review 5.  A new look at coronary angiograms: plaque morphology as a help to diagnosis and to evaluate outcome.

Authors:  J Lespérance; P Théroux; G Hudon; D Waters
Journal:  Int J Card Imaging       Date:  1994-06

6.  Prognostic significance of transient myocardial ischaemia after first acute myocardial infarction: five year follow up study.

Authors:  H Mickley; J R Nielsen; J Berning; A Junker; M Møller
Journal:  Br Heart J       Date:  1995-04

Review 7.  Thrombus aspiration in primary angioplasty for ST-segment elevation myocardial infarction.

Authors:  Roberta Serdoz; Michele Pighi; Nikolaos V Konstantinidis; Ismail Dogu Kilic; Sara Abou-Sherif; Carlo Di Mario
Journal:  Curr Atheroscler Rep       Date:  2014-08       Impact factor: 5.113

8.  Identification of patients at high risk for adverse coronary events while awaiting routine coronary angioplasty.

Authors:  M Chester; L Chen; J C Kaski
Journal:  Br Heart J       Date:  1995-03

Review 9.  Treating thrombus in the coronary arteries.

Authors:  B Boztosun; R D Acar
Journal:  Herz       Date:  2013-08-08       Impact factor: 1.443

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.